Abstract:Objective To investigate the relationship between the expression of vascular endothelial growth factor (VEGF), its receptors FLT-1, FLK-1/KDR and tumor angiogenesis, clinical staging, lymph node metastasis in non-small cell lung cancer (NSCLC). Methods Immunohistochemical staining and enzyme-linked immunosorbent assay (ELISA) were used to detect the levels of VEGF and its receptors FLT-1,FLK-1/KDR in the tissue and serum of 112 patients with NSCLC, and analysed their clinical significances. Results The expression of VEGF and its receptors FLT-1, FLK/KDR in lung tissue of NSCLC were significantly higher than that in normal alveolar tissue and paracancerous tissue (P<0.05) and they increased significantly in proportion with clinical stages Ⅰ, Ⅱ, Ⅲ-Ⅳ (P<0.05). The positive rates of VEGF and its receptors FLT-1, FLK-1/KDR in lymph node metastasis group were significantly higher than those without lymph node metastasis group (P<0.05). Se- rum VEGF in NSCLC was significantly higher than that in the control group and also increased according to clinical staging (Ⅰ, Ⅱ, Ⅲ-Ⅳ; P<0.05). Serum VEGF was significantly higher in the lymph node metastasis group than that of the absence group (P<0.05) . Conclusions The expression of VEGF and its receptors FLT-1, FLK/KDR in NSCLC increased significantly, and positively correlated with tumor development, progression and lymph node metastasis. Serum VEGF is an important marker of hyperplasia and metastasis in NSCLC.

Research Advancement of Vascular Endothelial Growth Factor in Colorectal Cancer Liver Metastases

The Effect of Anti-Vegf Drugs (bevacizumab and Aflibercept) on the Survival of Patients with Metastatic Colorectal Cancer (Mcrc)

Anti-angiogenic therapy for colorectal cancer: on the way to getting better!

Advancement of the relationship between vascular endothelial growth factor receptors and angiogenesis of hepatocellular carcinoma

Research Advance in Vascular Endothelial Growth Factor and Anti-Tumor

The relationship of vascular endothelial growth factor and micro vascular density with the invasion, metastasis and prognosis of colorectal carcinoma

Research progress of vascular endothelial growth factor in progression and prognosis of oral squamous cell carcinoma

The Vascular Endothelial Growth Factor Family and Antiangiogesis Therapy

Progression of VEGF-targeted cancer therapy

Relationships of VEGF and Microvessel Density with Liver Metastasis in Human Colorectal Cancer

Expression and clinical study of vascular endothelial growth factor and its receptors FLT-1, FLK-1/KDR in non-small cell lung cancer

Studies on the Relationship Between VEGF -C and Lymphangiogenesis and Lymph Node Metastasis in Tumor

The Impact of VEGF on Cancer Metastasis and Systemic Disease.

Vascular endothelial growth factor pathway's influence on bevacizumab efficacy in metastatic colorectal cancer treatment

VEGF and It's Interdiction in Anti-tumor Therapy

Vascular Endothelial Growth Factor and Its Receptor Involved in Non-Small Cell Lung Cancer Angiogenesis

Advances in Treatment of Liver Metastasis of Colorectal Cancer

The Correlation Between Expression of Vascular Endothelial Growth Factor and Invasiveness and Metastasis of Gastric Carcinoma

Expression and Clinical Significance of Vascular Endothelial Growth Factor in Rectal Cancers

VEGF, VEGFR and Their Impact on Angiogenesis of Hepatocellular Carcinoma

Synergistic Antitumor Effects of Cmet Inhibitor in Combination with Anti-Vegf in Colorectal Cancer Patient-Derived Xenograft Models